PDSB
PDS Biotechnology Corp
0.7971$
-0.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.9% | +16.2% | -12.3% | -13.3% | -13.5% | +3.7% | -13.9% | -14.3% | -12.1% | -19.1% | -64.3% | |
| – | +3.9% | +16.3% | -12.4% | -13.3% | -13.6% | -5.7% | -20.8% | -17.1% | +1.3% | -19.0% | -69.2% | |
| – | +4.3% | +17.8% | -13.4% | -13.8% | -16.2% | -4.1% | -20.3% | -17.8% | +2.0% | -18.9% | -74.2% | |
| – | +4.3% | +17.8% | -13.4% | -13.8% | -16.2% | -4.1% | -20.3% | -17.8% | +2.0% | -18.9% | -74.2% | |
| – | +1.7% | -4.3% | -7.1% | +2.9% | -13.5% | -6.4% | -0.6% | +3.0% | -15.9% | -2.2% | -40.4% | |
| – | +48.9% | +10.5% | +4.1% | +17.0% | -6.8% | +6.9% | -36.9% | +15.6% | -28.9% | +7.0% | +22.0% | |
| – | +7,642.4% | +74.0% | +42.5% | +19.9% | +0.0% | 0.0% | -55.8% | +8.9% | -14.5% | +1.4% | -16.9% | |
| – | +30.1% | -14.1% | -45.8% | -60.0% | +29.5% | +69.7% | +57.3% | +15.2% | -31.0% | +2.1% | +75.2% | |
| – | -16.7% | -14.6% | -17.1% | -12.9% | -23.5% | -31.0% | +103.8% | -8.1% | -1.3% | -9.6% | – | |
| – | +6.7% | +42.3% | -16.8% | -28.8% | -13.6% | +17.7% | -28.6% | -40.8% | -2.1% | -57.9% | -192.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2.5% | +9.9% | +5.4% | +0.3% | -1.0% | +11.2% | +13.3% | +2.1% | -1.0% | +19.6% | +0.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.